dihydrofolic acid

Dihydrofolic acid (7,8-Dihydrofolic acid) is a folic acid derivative that produces tetrahydrofolic acid in the presence of dihydrofolic acid reductase.

Dihydrofolic acid (Standard) is a reference standard for research and analysis in studies involving Dihydrofolic acid. Dihydrofolic acid (7,8-Dihydrofolic acid) is a folic acid derivative that produces tetrahydrofolic acid in the presence of dihydrofolic acid reductase.

Sulfamerazine (RP2632) is a long-acting sulfanilamide antibacterial agent. Sulfamerazine inhibits bacterial synthesis of dihydrofolic acid by competing with para-aminobenzoic acid (PABA) for the binding site on dihydropteroate synthase.

Sulfamerazine D4, a deuterium-labeled version of Sulfamerazine, acts as a sulfonamide antibacterial. It inhibits the bacterial synthesis of dihydrofolic acid by competing with para-aminobenzoic acid (PABA) for the binding site on dihydropteroate synthase.

Aditoprime (Aditoprim) is a selective inhibitor of bacterial dihydrofolate reductase (DHFR) that exhibits potent enzymatic inhibition with IC50 values of 47 nM for Escherichia coli DHFR and 520 nM for Lactobacillus casei DHFR, Aditoprime functions by blocking the conversion of dihydrofolic acid to tetrahydrofolic acid.Aditoprime also demonstrate broad-spectrum antibacterial activity combined with favorable pharmacokinetic properties that support its use in antimicrobial research and drug development studies.

Sulfamerazine (Standard) is the standard substance of Sulfamerazine, and it is applicable for quantitative analysis, quality control, and related research in biochemical experiments. Sulfamerazine (RP2632) is a long-acting sulfanilamide antibacterial agent. Sulfamerazine inhibits bacterial synthesis of dihydrofolic acid by competing with para-aminobenzoic acid (PABA) for the binding site on dihydropteroate synthase.